Ebola vaccine to be used on human test subjects

Baltimore-based Profectus BioSciences in the coming months will begin a human clinical trial for its Ebola vaccine after a successful animal study.

To find more details on this follow the link below to the article posted by the Baltimore Business Journal

http://www.bizjournals.com/baltimore/blog/cyberbizblog/2015/04/ebola-vaccine-by-baltimores-profectus-biosciences.html.